Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL

被引:0
作者
G. Biolcati
S. Hanneken
E. I. Minder
N. J. Neumann
J. H. P. Wilson
P. J. Wolgen
D. J. Wright
A. J. Lloyd
机构
[1] Istituto Dermatologico S. Gallicano - Istituti Fisioterapici Ospitalieri,Centre for Porphyrias
[2] Private Practice Empoderm,Department of Dermatology
[3] Stadtspital Triemli,The Department of Internal Medicine, Center of Lysosomal and Metabolic Diseases
[4] Porphyria Outpatient Clinics,undefined
[5] Heinrich Heine University,undefined
[6] Erasmus Medical Center,undefined
[7] Clinuvel Pharmaceuticals Limited,undefined
[8] Acaster Lloyd Consulting Ltd,undefined
来源
Journal of Patient-Reported Outcomes | / 5卷
关键词
Erythropoietic protoporphyria; EPP-QoL; Patient reported outcomes; Psychometric validation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 27 条
  • [1] Benjamin K(2017)Patient-reported outcome and observer-reported outcome assessment in rare disease clinical trials: An ISPOR COA emerging good practices task force report Value Health 20 838-855
  • [2] Vernon M(1994)Dermatology life quality index (DLQI)-a simple practical measure for routine clinical use Clin Exp Dermatol 19 210-216
  • [3] Patrick D(2006)Erythropoietic protoporphyria in the U.K.: Clinical features and effect on quality of life Br J Dermatol 155 574-581
  • [4] Finlay A(2005)Translating the science of quality of life into practice: What do dermatology life quality index scores mean? J Investig Dermatol 125 659-664
  • [5] Khan G(2008)The quality of life of 790 patients with photodermatoses Br J Dermatol 159 192-197
  • [6] Holme S(2009)Erythropoietic protoporphyria Orphanet J Rare Dis 4 19-900
  • [7] Anstey A(2000)Recommendations on health-related quality of life research to support labeling and promotional claims in the United States Qual Life Res 9 887-310
  • [8] Finlay A(2004)The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A Report from the WHOQOL Group Qual Life Res 13 299-766
  • [9] Hongbo Y(1994)Erythropoietic protoporphyria Br J Dermatol 131 751-483
  • [10] Thomas C(1992)The MOS 36-ltem short-form health survey (SF-36) Med Care 30 473-undefined